Lv611
2400 积分 2023-08-25 加入
Switching to subcutaneous zilucoplan from intravenous complement component 5 inhibitors in generalised myasthenia gravis: a phase IIIb, open-label study
8天前
已完结
Targeting Bruton’s tyrosine kinase (BTK) as a signaling pathway in immune-mediated diseases: from molecular mechanisms to leading treatments
9天前
已完结
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
17天前
已完结
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
17天前
已完结
Subcutaneous batoclimab in generalized myasthenia gravis: Results from a Phase 2a trial with an open‐label extension
17天前
已完结
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study
17天前
已完结
Remibrutinib in Chronic Spontaneous Urticaria
20天前
已完结
Remibrutinib in Chronic Spontaneous Urticaria
20天前
已完结
中国重症肌无力诊断和治疗指南（2025版）
23天前
已完结
Long‐term efficacy of eculizumab in refractory generalized myasthenia gravis: responder analyses
24天前
已完结
皖公网安备34019202002308
